References
- Hooper, D. C. and Rubinstein, E. : Quinolone antimicrobial agents. ASM Press. (2003).
- Emmerson, A. M. and Jones, A. M. : The quinolones: decades of development and use. J. Antimicrob. Chemother. 51(Suppl. S1), 13 (2003).
- Levy, S. B. and Marshall, B. : Antibacterial resistance worldwide: causes, challenges and responses. Nat. Med. 10, s122 (2004). https://doi.org/10.1038/nm1145
- Oh, J. I., Paek, K. S., An, M. J., Kim, M. Y., Hong, C. Y., Kim, I. C. and Kwak, J. H. : In vitro and in vivo evaluations of LB20304, a new Fluoronaphthyridone. Antimicrob. Agents Chemother. 40, 1564 (1996).
- Park, H. S., Kim, H. J., Seol, M. J., Choi, D. R., Choi, E. C. and Kwak, J. H. : In vitro and in vivo antibacterial activities of DW-224a, a new fluoronaphthyridone. Antimicrob. Agents Chemother. 50, 2261 (2006). https://doi.org/10.1128/AAC.01407-05
- Kim, H. J., Seol, M. J., Park, H. S., Choi, D. R., Seong, S. K., Shin, H. K. and Kwak, J. H. : Antimicrobial activity of DW- 224a, a new fluoroquinolone, against Streptococcus pneumoniae. J. Antimicrob. Chemotherapy 57, 1256 (2006). https://doi.org/10.1093/jac/dkl144
- Kwon, A. R., Min, Y. H., Ryu, J. M., Choi, D. R., Shim, M. J. and Choi, E. C. : In vitro and in vivo activities of DW-224a, a novel fluoroquinolone antibiotic agent. J. Antimicrob. Chemother. 58, 684 (2006). https://doi.org/10.1093/jac/dkl304
- Kosowska-Shick, K., Credito, K., Pankuch, G. A., Lin, G., Bozdogzn, B., McGhee, P., Dewasse, B., Choi, D. R., Ryu, J. M. and Appelbaum, P. C. : Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents. Antimicrob. Agents Chemother. 50, 2064 (2006). https://doi.org/10.1128/AAC.00153-06
- Clinical and Laboratory Standards Institute (CLSI), Performance standards for antimicrobial susceptibility testing; 15th informational Supplement. Document M100-S15, CLSI, Wayne, PA (2005).
- Bliss, C. I. : Statistics in bioassay. Academic Press, Inc., New York (1985).
- Acar, J. F. and Francoual, S. : The clinical problems of bacterial resistance to the new quinolones. J. Antimicrob. Chemother. 26(Suppl B), 207 (1990). https://doi.org/10.1093/jac/26.suppl_B.207
- Hamett, N., Brown, S. and Krishnan, C. : Emergence of quinolone resistance among clinical isolate of methicillinresistant Staphylococcus aureus in Ontario, Canada. Antimicrob. Agents Chemother. 35, 1911 (1991). https://doi.org/10.1128/AAC.35.9.1911
- Domagala, J. M. : Structure-activity and structure-side effect relationships for the quinolone antibacterials. J. Antimicrob. Chemother. 33, 685 (1994). https://doi.org/10.1093/jac/33.4.685
- Hong, C. Y., Kim, Y. K., Lee, Y. H. and Kwak, J. H. : Methyloxime-substituted aminopyrrolidine: A new surrogate for 7-basic group of quinolone. Bioorganic & Medical Chemistry Letters. 8, 221 (1998). https://doi.org/10.1016/S0960-894X(97)10222-0
- Kim, E. J., Shin, W. H., Kim, K. S. and Han, S. S. : Safety pharmacology of DW-224a, a novel fluoroquinolone antibiotic agent. Drug Chem. Toxicol. 27, 295 (2004). https://doi.org/10.1081/DCT-200039708
- Han, J., Kim, J. C., Chung, M. K., Kim, B. and Choi, D. R. : Subacute toxicity and toxikinetics of a new antibiotics, DW- 224a, after single and 4-week repeated oral administration in dogs. Biol. Pharm. Bull. 26, 832 (2003). https://doi.org/10.1248/bpb.26.832
- Park, H. S., Jung, S. J., Choi, D. R., Choi, E. C. and Kwak, J. H. : DNA gyrase and topoisomerase IV are dual targets of zabofloxacin in Streptococcus pneumoniae. Int. J. Antimicrob. Agents. 36, 97 (2010). https://doi.org/10.1016/j.ijantimicag.2010.02.022